Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline mao-b inhibitors use: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1171 ◽

2019 ◽

Vol 405 ◽

pp. 202

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Mao B ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1167 ◽

2019 ◽

Vol 405 ◽

pp. 200

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Body Mass Index ◽

Parkinson's Disease ◽

Adverse Events ◽

Body Mass ◽

Baseline Body Mass Index ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1170 ◽

2019 ◽

Vol 405 ◽

pp. 201-202

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Disease Severity ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc ◽

Baseline Disease Severity

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline dopamine agonist use: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1168 ◽

2019 ◽

Vol 405 ◽

pp. 200-201

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Dopamine Agonist ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1169 ◽

2019 ◽

Vol 405 ◽

pp. 201

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1172 ◽

2019 ◽

Vol 405 ◽

pp. 202-203

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Onset of drug-related adverse events in Parkinson's disease patients treated with opicapone in clinical practice: OPTIPARK post-hoc analysis

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2020.06.232 ◽

2020 ◽

Vol 79 ◽

pp. e61-e62

Author(s):

A. Lees ◽

H. Reichmann ◽

J.F. Rocha ◽

D. Magalhães ◽

P. Soares-da-Silva

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Practice ◽

Adverse Events ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis

Journal of Parkinson s Disease ◽

10.3233/jpd-150758 ◽

2016 ◽

Vol 6 (2) ◽

pp. 401-411 ◽

Cited By ~ 5

Author(s):

Nir Giladi ◽

Mahnaz Asgharnejad ◽

Lars Bauer ◽

Frank Grieger ◽

Babak Boroojerdi

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Mao B ◽

Post Hoc Analysis ◽

Post Hoc ◽

Early Parkinson’S Disease

Download Full-text

Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials

Journal of Neurology ◽

10.1007/s00415-017-8671-0 ◽

2017 ◽

Vol 265 (2) ◽

pp. 253-265 ◽

Cited By ~ 9

Author(s):

Masahiro Nomoto ◽

Hirotaka Iwaki ◽

Hiroyuki Kondo ◽

Masaya Sakurai

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Elderly Patients ◽

Controlled Trials ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.p06.088 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. P06.088-P06.088

Author(s):

R. Hauser ◽

P. Nausieda ◽

E. Surmann ◽

K. Moran ◽

P. Barone

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Anxiety And Depression ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Rotigotine Transdermal System ◽

Post Hoc

Download Full-text

Correction to: Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials

Journal of Neurology ◽

10.1007/s00415-017-8706-6 ◽

2017 ◽

Vol 265 (2) ◽

pp. 266-272

Author(s):

Masahiro Nomoto ◽

Hirotaka Iwaki ◽

Hiroyuki Kondo ◽

Masaya Sakurai

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Elderly Patients ◽

Controlled Trials ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text